How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more?

How will the Clin­i­cians, Patients and Con­sumers of the Future ensure appro­pri­ate use of brain enhance­ment meth­ods encom­pass­ing lifestyle, sup­ple­ments, brain train­ing, med­i­ta­tion, bio/ neu­ro­feed­back, tDCS and more? (record­ing requires reg­is­tra­tion; view slid­edeck above or Here)

• Dr. Eddie Mar­tuc­ci, Co-Founder and CEO of Akili Inter­ac­tive Labs
• Dr. Anna Wexler, sci­ence writer, film­mak­er and post­doc fel­low at the Depart­ment of Med­ical Ethics and Health Pol­i­cy at UPenn’s Perel­man School of Medicine
• Dr. Olivi­er Oul­li­er, Pres­i­dent of EMOTIV 
• Dr. Peter Rein­er, Co-Founder of the Nation­al Core for Neu­roethics at the Uni­ver­si­ty of British Columbia
• Chaired by: Dr. Ali­son Fen­ney, Exec­u­tive Direc­tor of the Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion (NIO)

Slid­edeck above sup­port­ed ses­sion held dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit: Brain Health & Enhance­ment in the Dig­i­tal Age (Decem­ber 5–7th).